311
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Monetary Value of Disability-Adjusted Life Years and Potential Productivity Losses Associated With Neglected Tropical Diseases in the East African Community

ORCID Icon & ORCID Icon
Pages 35-47 | Received 06 Feb 2023, Accepted 16 Jun 2023, Published online: 29 Jun 2023

References

  • East African Community [EAC]. EAC partner states. Arusha: EAC; 2022. Available from: https://www.eac.int/. Accessed November 29, 2022.
  • International Monetary Fund (IMF). World economic and financial surveys: world economic outlook database. WEO Data. Washington, D.C: IMF; 2022. Available from: https://www.imf.org/en/Publications/WEO/weo-database/2021/October. Accessed November 29, 2022.
  • World Health Organization [WHO]. Macroeconomics and Health: Investing in Health for Economic Development. Geneva: World Health Organization; 2001.
  • Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Results. Seattle, United States: Institute for Health Metrics and Evaluation (IHME); 2020. Available from: https://vizhub.healthdata.org/gbd-results/. Accessed June 16, 2023.
  • World Health Organization. The world health report 2000. Health systems: improving performance. Geneva: World Health Organization; 2000.
  • Commission on Social Determinants of Health (CSDH). Closing the gap in a generation: health equity through action on the social determinants of health. Final Report of the (CSDH) Commission on Social Determinants of Health. Geneva: World Health Organization; 2008.
  • World Health Organization. The world health report 2013 – research for universal health coverage. Geneva: World Health Organization; 2013.
  • World Health Organization, Global Health Observatory. UHC service coverage index (SDG 3.8.1). Geneva: World Health Organization; 2022. Available from: https://www.who.int/data/gho/data/indicators/indicator-details/GHO/uhc-index-of-service-coverage. Accessed December 1, 2022.
  • GBD 2019 Human Resources for Health Collaborators. Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2022;399(10341):2129–2154. doi:10.1016/S0140-6736(22)00532-3
  • World Health Organization. Global Health Expenditure Database. Geneva: World Health Organization; 2022. Available from: https://apps.who.int/nha/database/Select/Indicators/en. Accessed November 15, 2022.
  • McIntyre D, Meheus F, Røttingen J-A. What level of domestic government health expenditure should we aspire to for universal health coverage? Health Econ Policy Law. 2017;12:125–137. doi:10.1017/S1744133116000414
  • World Health Organization. World Health Statistics 2022: Monitoring Health for the SDGs. Geneva: World Health Organization; 2022.
  • Kirigia JM, Ota MO, Senkubuge F, Wiysonge CS, Mayosi BM. Developing the African national health research systems barometer. Health Res Policy Sys. 2016;14:53. doi:10.1186/s12961-016-0121-4
  • Kirigia JM, Pannenborg CO, Amore LGC, Ghannem H, IJsselmuiden C, Nabyonga-Orem J. Global Forum 2015 dialogue on “From evidence to policy – thinking outside the box”: perspectives to improve evidence uptake and good practices in the African Region. BMC Health Serv Res. 2016;16(Suppl 4):215. doi:10.1186/s12913-016-1453-z
  • Rusakaniko S, Makanga M, Ota M, et al. Strengthening national health research systems in the WHO African Region – progress towards universal health coverage. Global Health. 2019;15:50. doi:10.1186/s12992-019-0492-8
  • United Nations (UN). Transforming our world: the 2030 agenda for sustainable development. General Assembly Resolution A/RES/70/1. New York: UN; 2015.
  • Card WI, Mooney GH. What is the monetary value of a human life? Br Med J. 1977;2(6103):1627–1629. doi:10.1136/bmj.2.6103.1627
  • Rice DP. Cost of illness studies: what is good about them? Inj Prev. 2000;6(3):177–179. doi:10.1136/ip.6.3.177
  • Andrade MV, Noronha K, Diniz BPC, et al. The economic burden of malaria: a systematic review. Malar J. 2022;21(1):283. doi:10.1186/s12936-022-04303-6
  • Sunyoto T, Boelaert M, Meheus F. Understanding the economic impact of leishmaniasis on households in endemic countries: a systematic review. Expert Rev Anti Infect Ther. 2019;17(1):57–69. doi:10.1080/14787210.2019.1555471
  • Keating J, Yukich JO, Sutherland CS, Woods G, Tediosi F. Human African trypanosomiasis prevention, treatment and control costs: a systematic review. Acta Trop. 2015;150:4–13. doi:10.1016/j.actatropica.2015.06.003
  • Trevisan C, Devleesschauwer B, Schmidt V, Winkler AS, Harrison W, Johansen MV. The societal cost of Taenia solium cysticercosis in Tanzania. Acta Trop. 2017;165:141–154. doi:10.1016/j.actatropica.2015.12.021
  • Widdicombe J, Basáñez MG, Entezami M, Jackson D, Larrieu E, Prada JM. The economic evaluation of Cystic echinococcosis control strategies focused on zoonotic hosts: a scoping review. PLoS Negl Trop Dis. 2022;16(7):e0010568. doi:10.1371/journal.pntd.0010568
  • Keating J, Yukich JO, Mollenkopf S, Tediosi F. Lymphatic filariasis and onchocerciasis prevention, treatment, and control costs across diverse settings: a systematic review. Acta Trop. 2014;135:86–95. doi:10.1016/j.actatropica.2014.03.017
  • Marques AP, Ramke J, Cairns J, et al. The economics of vision impairment and its leading causes: a systematic review. EClinicalMedicine. 2022;46:101354. doi:10.1016/j.eclinm.2022
  • Oliveira LNDS, Itria A, Lima EC. Cost of illness and program of dengue: a systematic review. PLoS One. 2019;14(2):e0211401. doi:10.1371/journal.pone.0211401
  • de Broucker G, Sim SY, Brenzel L, Gross M, Patenaude B, Constenla DO. Cost of nine pediatric infectious illnesses in low- and middle-income countries: a systematic review of cost-of-illness studies. Pharmacoeconomics. 2020;38(10):1071–1094. doi:10.1007/s40273-020-00940-4
  • Murray CJ. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ. 1994;72(3):429–445.
  • Lopez AD, Mathers CD, Ezzati M, et al. Global Burden of Disease and Risk Factors. New York: Oxford University Press; 2006.
  • World Health Organization. WHO Methods and Data Sources for the Global Burden of Disease Estimates 2000–2019. Geneva: World Health Organization; 2020.
  • GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1204–1222. doi:10.1016/S0140-6736(20)30925-9
  • Chisholm D, Stanciole AE, Edejer TTT, Evans DB. Economic impact of disease and injury: counting what matters. BMJ. 2010;340:c924. doi:10.1136/bmj.c924
  • World Health Organization. WHO Guide to Identifying the Economic Consequences of Disease and Injury. World Health Organization; 2009.
  • International Labour Office (ILO). Resolution concerning statistics of work, employment and labour underutilization, Resolution I, 19th International Conference of Labour Statisticians; 2–11 Oct. Geneva: ILO; 2013.
  • The World Bank. Data. Labour force participation rate - Sub-Saharan Africa. Washington, D.C: The World Bank; 2022. Available from: https://data.worldbank.org/indicator/SL.TLF.ACTI.ZS?locations=ZG. Accessed December 1, 2022.
  • Danish Trade Union Development Agency (DTDA). Burundi Labour Market Profile 2021/2022. Copenhagen: Danish Trade Union Development Agency; 2021.
  • Republic of Kenya. Quarterly Labour Force Report. Quarter 1, 2019. Nairobi: Kenya National Bureau of Statistics; 2019.
  • Republic of Rwanda. Labour Force Survey Annual Report, December 2018. Kigali: National Institute of Statistics of Rwanda (NISR); 2018.
  • Republic of Uganda. Annual labour force survey 2018/19 report. Kampala: Uganda Bureau of Statistics; 2019.
  • The United Republic of Tanzania. Integrated labour force survey 2020/21. National Bureau of Statistics (NBS) and Office of the Government Statistician Zanzibar, Dar es Salaam; 2021.
  • Meru University of Science & Technology (MUST). Standard operating procedures of the Must Institutional Research Ethics Review Committee (MIRERC). Document WI‐1‐39‐4. Meru: MIRERC; 2017.
  • Kirigia JM, Mwabu GM. The monetary value of disability-adjusted-life-years lost in the East African Community in 2015. Mod Econ. 2018;9:1360–1377. doi:10.4236/me.2018.97087
  • Kirigia JM, Mburugu GN. The monetary value of human lives lost due to neglected tropical diseases in Africa. Infect Dis Poverty. 2017;6:165. doi:10.1186/s40249-017-0379-y
  • Stiglitz JE, Amartya S, Jean-Paul F. Mismeasuring our lives: why GDP doesn’t add up: the report. New York: The New Press; 2010.
  • GBD 2016 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390(10100):1260–1344. doi:10.1016/S0140-6736(17)32130-X
  • Solberg CT, Sorheim P, Muller KE, Gamlund E, Norheim OF, Barra M. The devils in the DALY: prevailing evaluative assumptions. Public Health Ethics. 2020;13(3):259–274. doi:10.1093/phe/phaa030
  • Schroeder SA. Which values should be built into economic measures? Econ Philos. 2019;35(3):521–536. doi:10.1017/S0266267118000317
  • Landefeld JS, Seskin EP. The economic value of life: linking theory to practice. Am J Public Health. 1982;72:555–566. doi:10.2105/AJPH.72.6.555
  • Shiell A, Gerard K, Donaldson C. Cost of illness studies: an aid to decision-making? Health Policy. 1987;8(3):317–323. doi:10.1016/0168-8510(87)90007-8
  • Koopmanschap MA, van Ineveld BM. Towards a new approach for estimating indirect costs of disease. Soc Sci Med. 1992;34(9):100–1010. doi:10.1016/0277-9536(92)90131-9
  • International Labour Organization (ILO). Concept Note: informal economy in Africa: which way forward? In: Making Policy Responsive, Inclusive, and Sustainable. Geneva: ILO; 2022.
  • Drummond ME, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes. 3rd ed. Oxford: Oxford University Press; 2007.
  • Sutherland CS, Yukich J, Goeree R, Tediosi F. A literature review of economic evaluations for a neglected tropical disease: human African trypanosomiasis (“sleeping sickness”). PLos Negl Trop Dis. 2015;9(2):e0003397. doi:10.1371/journal.pntd.0003397
  • Turner HC, Walker M, Pion SDC, McFarland DA, Bundy DAP, Basanez M-G. Economic evaluations of onchocerciasis interventions: a systematic review and research needs. Trop Med Int Health. 2019;24(7):788–816. doi:10.1111/tmi.13241
  • Uzoegbo SC, Jackson LJ, Bloch SCM. A systematic review and quality appraisal of the economic evaluations of schistosomiasis interventions. PLoS Negl Trop Dis. 2022;16(10):e0010822. doi:10.1371/journal.pntd.0010822
  • Kirigia JM. Economic Evaluation of Public Health Problems in Sub-Saharan Africa. Nairobi: University of Nairobi Press; 2009.
  • Kirigia JM. Cost-utility analysis of schistosomiasis intervention strategies in Kenya. Environ Dev Econ. 1998;3(3):319–346. doi:10.1017/S1355770X98000187
  • Aehyung K, Benton B. Cost-Benefit Analysis of the Onchocerciasis Control Program (OCP). Washington, D.C: The World Bank; 1995.
  • Kirigia JM, Sambo LG, Kainyu LH. A cost-benefit analysis of preventive schistosomiasis interventions in Kenya. Afr J Health Sci. 2000;7(3–4):5–11.
  • United Nations (UN), The International Bill of Human Rights, Universal Declaration of Human Rights. Adopted and proclaimed by General Assembly resolution 217 A (III) of 10 December 1948. New York: UN; 1948.
  • United Nations (UN), International Covenant on Economic, Social and Cultural Rights. Adopted and opened for signature, ratification and accession by general assembly resolution 2200 A (XXI) of 16 December 1966. New York: UN; 1966.